Friday, October 14, 2016

Unguentum M (Almirall Limited )





1. Name Of The Medicinal Product



Unguentum M


2. Qualitative And Quantitative Composition



There is no specific active ingredient.



3. Pharmaceutical Form



Cream



4. Clinical Particulars



4.1 Therapeutic Indications



Unguentum M has emollient properties and is recommended for the symptomatic treatment of dermatitis, nappy rash, ichthyosis, eczema, protection of raw and abraded skin areas, pruritus and related skin conditions where dry scaly skin is a problem, and as a pre-bathing emollient for dry/eczematous skin, to alleviate drying effects.



Unguentum M is to be used as a diluent for various topical corticosteriod formulations in those instances where a lower strength preparation is considered desirable by the physician and as a general base for extemporaneous dispensing.



4.2 Posology And Method Of Administration



A thin application of the cream should be gently massaged into the skin three times daily or at appropriate intervals.



When used as a protective cream Unguentum M should be applied sparingly to the affected areas of the skin before, or immediately after, exposure to a potentially harmful factor.



4.3 Contraindications



Unguentum M should not be used:



- if hypersensitivity to any of the ingredients is known.



- near the eyes and on mucous membranes.



4.4 Special Warnings And Precautions For Use



Sorbic acid and Cetostearyl alcohol may cause local skin reactions, (e.g. contact dermatitis)



Propylenglycol may cause skin reactions.



Ingestion of Unguentum M should be avoided.



4.5 Interaction With Other Medicinal Products And Other Forms Of Interaction



None.



4.6 Pregnancy And Lactation



No evidence of any harmful effect on the use of Unguentum M in pregnancy and lactation.



4.7 Effects On Ability To Drive And Use Machines



None.



4.8 Undesirable Effects



Rarely (1 in 10 out of 10,000 persons treated) skin irritation such as burning sensations and reddening or allergic contact dermatitis may occur.



4.9 Overdose



None.



5. Pharmacological Properties



5.1 Pharmacodynamic Properties



Unguentum M is an ambiphilic topical preparation with emollient properties which maintains the high lipid content of an ointment but also has the water miscible characteristics of a cream. The high lipid content reduces water loss from the skin and therefore has a hydrating effect which permits the recovery from dermatitis, eczema, and dry or scaly skin conditions. Unguentum M also contains sorbic acid which has an antibacterial effect.



5.2 Pharmacokinetic Properties



Unguentum M is for topical use only and contains no specific active ingredient. There are no phamacokinetic data for this product.



5.3 Preclinical Safety Data



--



6. Pharmaceutical Particulars



6.1 List Of Excipients



Purified water, white soft paraffin, cetostearyl alcohol, polysorbate 40, propylene glycol, glycerol monostearate 40 – 50, liquid paraffin, medium-chain triglycerides, sorbic acid, colloidal anhydrous silica, sodium hydroxide.



6.2 Incompatibilities



None.



6.3 Shelf Life



Aluminium tubes: 5 years



Plastic containers: 3 years



6.4 Special Precautions For Storage



None.



6.5 Nature And Contents Of Container



Aluminium tubes. Content: 10g, 15g, 30g, 50g, 60g, 80g and 100g.



Plastic jars. Content: 100g, 500g and 900g.



Plastic tubs. Content: 8kg, l0kg and 50kg.



Plastic bag in metal tins. Content: 5kg, l0kg and 25kg.



Plastic pump dispensers. Content: 75ml and 200ml.



6.6 Special Precautions For Disposal And Other Handling



None.



7. Marketing Authorisation Holder



Almirall Hermal GmbH



Scholtzstrasse 3



D-21465 Reinbek



Germany



8. Marketing Authorisation Number(S)



PL 33016/0014



9. Date Of First Authorisation/Renewal Of The Authorisation



12/09/2005



10. Date Of Revision Of The Text



19th October 2010




No comments:

Post a Comment